Intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025
London, UK, 13 February 2025: European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit development works of a 90,255 sq ft former GSK laboratory at its 28-acre life science campus, Riverlabs, is now underway. This transformation will deliver an adaptable and highly specified sustainable R&D facility, at the most affordable cost to occupiers in the Golden Triangle.
The state-of-the-art…
On 30 January, a high-level delegation from the Department for Science, Innovation and Technology (DSIT) visited Norwich Research Park, to see the cutting edge research and innovation in Engineering Biology that is being conducted on campus.
The team, led by Dr. Isabel Webb, Deputy Director for Technology Strategy and Security, visited Norwich Research Park’s BBSRC (Biotechnology and Biological Sciences Research Council) research institutes - the Quadram Institute, Earlham Institute and John Innes Centre.Hosted by Roz Bird, CEO of Anglia Innovation Partnership, the campus management company…
To mark the 10th anniversary of the United Nation’s ‘International Day of Women and Girls in Science’ on February 11th, 2025 - AMSBIO has interviewed Dr Zoe Hewitt, an expert in cell and gene therapy manufacturing, and co-founder of Regen CTC*.
In this insightful Q&A, Dr Hewitt reflects on her unexpected journey into science, the barriers women still face in science and practical steps to drive greater diversity in life sciences. Topics include what inspired her career in science, the importance of early role models, her work in developing cells to be used in a…
Learn to Discover (L2D) is a cutting edge online training course in Python programming, data science and machine learning, tailored for health, disease and bioscience. L2D is accredited for CPD purposes by the Royal College of Physicians and the Royal Society of Biology and was developed at University College London.
To register your interest, please contact: admin@learntodiscover.ai
Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer Group and Novo Nordisk’s 2025 Golden Ticket Programme.
The 2025 Golden Ticket Programme was open to early-stage biotech companies focused on novel drug targets and transformational medicines in cardiometabolic diseases, rare blood and rare endocrine disorders, with robust research plans and potential for successful research development.
Following a competitive pitch process reviewed by the…
3 July | Babraham Research Campus
Introducing ON Helix 2025Enabling the future of patient treatments takes more than just great science - it takes an ecosystem of life science professionals working together to move innovations forward. ON Helix presents a unique opportunity to engage with Cambridge’s world-class translational research ecosystem under the theme of New Horizons for Bio Innovation.
Whether you want to showcase your expertise, build visibility of your brand, or connect with industry leaders, there is a role for you at ON Helix!…
London, February 11, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health”) and is pleased to announce the placement of Jonathan Sadeh M.D., M.Sc.,as Executive Vice President, Chief Medical Officer and Head of R&D.Bausch Health is a global company that develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry,…
Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance
Glasgow, UK, 11 February 2025: Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced the appointment of Dr Michael Murray as Chair of the Board. He will work with the team to accelerate the company’s growth and help guide the commercialisation of its technology. The company has also expanded its scientific advisory board (SAB), adding Dr Nel Moore to support the development…
Pioneer Group, a leader in life science infrastructure and venture-building, has appointed industry leader, Chris Walters, as Portfolio Director and European Acquisitions Lead.
Chris brings extensive experience in life sciences real estate, supported by a strong network of relationships across academia, research institutes, public sector bodies and real estate capital. His appointment will play a pivotal role in advancing Pioneer’s growth strategy and strengthening its position as a global leader in science-focused commercial real estate.
Commenting on his appointment, Chris said: “I am…
Nominations are now officially open for the inaugural Private Business Awards
Sponsored by BDO, the awards serve to celebrate the UK’s mid-sized businesses that are driving UK economic growth
The Private Business Awards 2025, sponsored by BDO, has officially launched, with nominations now open to all UK registered private or PE-backed businesses with a turnover of £50m-£300m.
The inaugural awards programme, which serves to celebrate the mid-sized businesses that drive UK economic growth, aims to recognise the very best of private business in the UK.
The Private…